Patents
line
1
Pharmaceutical Compositions for Treatment of STK11-Mutated Cancer Comprising Cardiac Glycosides,
Yoon et al.,

Korean Patent Registration No.10-1701597 (2017)
2
Pharmaceutical Compositions for Treatment of STK11-Mutated Cancer Comprising Cardiac Glycosides,
Yoon et al.,

European Patent Application No.15 764825.4 (2016)
3
Compositions for treatment of mutated cancer comprising PDE4D inhibitor,
Yoon et al.,

Korean Patent Registration No.10-1661898 (2016)
4
Pharmaceutical Compositions for Treatment of STK11-Mutated Cancer Comprising Cardiac Glycosides,
Yoon et al.,

US Patent Application No.15/127299 (2016)
5
Pharmaceutical Compositions for Treatment of STK11-Mutated Cancer Comprising Cardiac Glycosides,
Yoon et al.,

International patent filing number PCT/KR2015/002755 (2015)
6
Pharmaceutical Compositions for Treatment of STK11-Mutated Cancer Comprising Cardiac Glycosides,
Yoon et al.,

Korean patent filing number 10-2015-003848 (2015)
7
Compositions for treatment of mutated cancer comprising PDE4D inhibitor,
Yoon et al.,

Korean patent filing number 10-2014-0015596 (2014)
8
Rhodanine derivatives exhibiting peroxisome proliferator-activated receptor activity,
Yoon et al.,

Korean patent filing number 10-2009-0006090 (2009)
9
Systems and Methods for Virtual Drug Screening,
Sukjoon Yoon and William J. Welsh

US patent filed on June, 2003, Serial No. 60/477,717
10
Methods for Prediction of Amyloid Fibril Formation and Identification of Peptides Useful as Therapeutic and Diagnostic Agents,
Sukjoon Yoon and William J. Welsh

(WO 2004/074313, 2004)
11
Implantable bioresorbable membranes and method for the preparation thereof,
Sukjoon Yoon, GD Yeo, YC Kim, MH Seo, CM Pai, JP Jung and SJ Lee

(USP 5,948,020, 1999)
12
Four Korean Patents ('95-'98, Samyang Pharmaceuticals)- registration # 1002621420000, 1001932850000, 1001656420000, 1001419880000